✦ LIBER ✦

Adjuvant treatment with interferon-α in melanoma stage II–III: experience of melanoma cooperative group

✍ Scribed by Ascierto, P.A.; Daponte, A.; Parasole, R.; Palmieri, G.; Mozzillo, N.; Castello, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant therapies in the treatment of s

✍ D. Kavanagh; A.D.K. Hill; B. Djikstra; R. Kennelly; E.M.W. McDermott; N.J. O’Hig 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Economic analysis of adjuvant therapy wi

✍ A. Lafuma; B. Dreno; M. Delaunay; C. Emery; F. Fagnani; K. Hieke; J.-J. Bonerand 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Circulating melanoma cells and distant m

✍ Alberto Fusi; Sandra Collette; Antonia Busse; Stefan Suciu; Anika Rietz; Mario S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 239 KB

PCN27 COST-EFFECTIVENESS OF HUMAN INTERF

✍ F Kasteng; R Stadler; G Wagenius; J Lundkvist 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Serum concentrations of pegylated interf

✍ Alexander M. M. Eggermont; Marna G. Bouwhuis; Wim H. Kruit; Alessandro Testori; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 341 KB

5LB Prognostic value of autoantibodies i

✍ M.G. Bouwhuis; S. Suciu; A. Testori; M. Santinami; W.H. Kruit; C.J. Punt; F. Sal 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 41 KB